NCT00332293View on ClinicalTrials.gov

AL-15469A for the Treatment of Bacterial Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

695

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Bacterial Conjunctivitis
Interventions
DRUG

Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5%

1 drop into the conjunctival sac of both eyes 3 times a day for 3 days

DRUG

Moxifloxacin hydrochloride ophthalmic solution 0.5% as base

1 drop into the conjunctival sac of both eyes 3 times a day for 3 days

Trial Locations (1)

76134

Contact Alcon for Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00332293 - AL-15469A for the Treatment of Bacterial Conjunctivitis | Biotech Hunter | Biotech Hunter